ASR Nederland N.V. (FRA:A16)
Germany · Delayed Price · Currency is EUR 59.98
+0.24 (0.40%)
Last updated: Jan 27, 2026, 8:06 AM CET
ASR Nederland Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Premiums & Annuity Revenue | 9,724 | 9,601 | 8,095 | 5,437 | 5,777 | 5,200 |
Total Interest & Dividend Income | 1,728 | 620 | -1,074 | 13,544 | 3,207 | 1,962 |
Gain (Loss) on Sale of Investments | 195 | 195 | 1,053 | -4,967 | 448 | 326 |
Other Revenue | 4,718 | 4,693 | 4,449 | -10,054 | 283 | 101 |
| 16,365 | 15,109 | 12,523 | 3,960 | 9,715 | 7,589 | |
Revenue Growth (YoY) | 7.90% | 20.65% | 216.24% | -59.24% | 28.01% | -5.67% |
Policy Benefits | 7,554 | 7,479 | 6,427 | 4,537 | 6,817 | 5,051 |
Policy Acquisition & Underwriting Costs | - | - | - | - | 526 | 516 |
Selling, General & Administrative | 1,542 | 1,555 | 1,373 | 1,120 | 725 | 701 |
Other Operating Expenses | 836 | 818 | 914 | 273 | 160 | 141 |
Total Operating Expenses | 10,108 | 10,028 | 8,856 | 5,965 | 8,249 | 6,437 |
Operating Income | 6,257 | 5,081 | 3,667 | -2,005 | 1,466 | 1,152 |
Interest Expense | -1,578 | -459 | -269 | -95 | -342 | -292 |
Currency Exchange Gain (Loss) | -2 | -2 | - | - | - | - |
Other Non Operating Income (Expenses) | -3,379 | -3,380 | -2,015 | -307 | 32 | 22 |
EBT Excluding Unusual Items | 1,298 | 1,240 | 1,383 | -2,407 | 1,156 | 882 |
Merger & Restructuring Charges | - | - | - | - | -4 | -7 |
Impairment of Goodwill | - | - | -13 | - | -9 | -117 |
Gain (Loss) on Sale of Assets | - | - | - | -33 | -26 | - |
Asset Writedown | 208 | 208 | -91 | 117 | 92 | 70 |
Pretax Income | 1,506 | 1,448 | 1,279 | -2,323 | 1,209 | 828 |
Income Tax Expense | 394 | 383 | 275 | -606 | 270 | 172 |
Earnings From Continuing Ops. | 1,112 | 1,065 | 1,004 | -1,717 | 939 | 656 |
Earnings From Discontinued Ops. | 33 | -121 | 82 | - | - | - |
Net Income to Company | 1,145 | 944 | 1,086 | -1,717 | 939 | 656 |
Minority Interest in Earnings | 1 | 2 | - | 8 | 3 | 1 |
Net Income | 1,146 | 946 | 1,086 | -1,709 | 942 | 657 |
Preferred Dividends & Other Adjustments | 70 | 63 | 48 | 48 | 48 | 48 |
Net Income to Common | 1,076 | 883 | 1,038 | -1,757 | 894 | 609 |
Net Income Growth | 71.05% | -12.89% | - | - | 43.38% | -32.41% |
Shares Outstanding (Basic) | 209 | 211 | 179 | 137 | 136 | 139 |
Shares Outstanding (Diluted) | 233 | 232 | 200 | 137 | 158 | 161 |
Shares Change (YoY) | 4.14% | 15.94% | 46.33% | -13.24% | -1.65% | 3.05% |
EPS (Basic) | 5.15 | 4.19 | 5.80 | -12.82 | 6.56 | 4.38 |
EPS (Diluted) | 4.69 | 3.87 | 5.26 | -12.82 | 5.77 | 3.90 |
EPS Growth | 66.44% | -26.50% | - | - | 47.98% | -34.40% |
Free Cash Flow | 55 | -724 | 3,568 | -1,140 | -188 | 340 |
Free Cash Flow Per Share | 0.24 | -3.12 | 17.80 | -8.32 | -1.19 | 2.12 |
Dividend Per Share | 3.230 | 3.120 | 2.890 | 2.700 | 2.420 | 2.040 |
Dividend Growth | 8.75% | 7.96% | 7.04% | 11.57% | 18.63% | 7.37% |
Operating Margin | 38.23% | 33.63% | 29.28% | -50.63% | 15.09% | 15.18% |
Profit Margin | 6.58% | 5.84% | 8.29% | -44.37% | 9.20% | 8.03% |
Free Cash Flow Margin | 0.34% | -4.79% | 28.49% | -28.79% | -1.93% | 4.48% |
EBITDA | 6,371 | 5,183 | 3,745 | -1,957 | 1,496 | 1,177 |
EBITDA Margin | 38.93% | 34.30% | 29.90% | -49.42% | 15.40% | 15.51% |
D&A For EBITDA | 114 | 102 | 78 | 48 | 30 | 25 |
EBIT | 6,257 | 5,081 | 3,667 | -2,005 | 1,466 | 1,152 |
EBIT Margin | 38.23% | 33.63% | 29.28% | -50.63% | 15.09% | 15.18% |
Effective Tax Rate | 26.16% | 26.45% | 21.50% | - | 22.33% | 20.77% |
Revenue as Reported | - | - | - | - | 10,036 | 7,743 |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.